|Celgene, the Dana-Farber Cancer Institute, and the University of Arkansas just announced the creation of the Myeloma Genome Project, tasked with compiling the largest ever set of genomic data from patients with Multiple Myeloma. The group has identified 2,100 patient data sets with corresponding clinical outcomes in an effort to provide a therapeutically meaningful classification system. The project is yet another example of collaboration and data sharing that promises to lead to faster diagnostics and treatments for diseases.
Formerly only available through an FIOA request, the FDA is now releasing data about “adverse events” related to foods, dietary supplements and cosmetics. The reports come directly from consumers and health care providers and can include minor complaints such as defective packaging as well as major medical events. The database provides information exactly as it was reported to the FDA, even if the agency has not determined that the product was actually the cause of the adverse event.